FDA Misses Deadline to Ban Formaldehyde in Hair Straighteners

THURSDAY, Jan. 8, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has again missed a deadline to propose a ban on chemicals in hair-straightening products that may pose a serious cancer risk.

Its target date for the proposed rule on formaldehyde was Dec. 31. No action has yet been taken.

An FDA spokesperson said the rule is still in the works.

“FDA”s proposed rule, “Use of Formaldehyde and Formaldehyde-Releasing Chemicals as an Ingredient in Hair Smoothing Products or Hair Straightening Products” continues to remain a priority for the Agency,” a spokesperson told CNN in an email.

“FDA may adjust the anticipated publication date of this and other proposed rules when appropriate,” the spokesperson said.

This is not the first delay. The FDA first planned to release the rule in October 2023.

“That timeline was later moved to April 2024, then November 2024, March 2025, July 2025 and now Dec. 31, 2025,” David Andrews, acting chief science officer of the nonprofit Environmental Working Group, told CNN.

“Formaldehyde is a well-established carcinogen that can also cause respiratory irritation, skin sensitization and other adverse health effects such as an increased risk of asthma,” Andrews added. “Every delay directly puts at risk the health of salon workers and consumers, particularly Black women, who are disproportionately exposed to harmful chemicals in personal care products.”

Formaldehyde and chemicals that release it when heated are often found in hair-smoothing and straightening treatments. These products are widely used and heavily marketed to Black women.

In 2021, salon workers and advocacy groups asked the FDA to ban formaldehyde in these products. While the agency later said it was considering a ban, no rule has been officially proposed.

There is no legal penalty for missing the deadline.

“Because this is not a legally mandated deadline, there are no formal consequences if it is missed,” Andrews said.

“Every day these products stay on the market further undermines public confidence in the FDA’s ability to safeguard health,” he added.

Scientists have linked hair-straightening products to higher risks of uterine, ovarian and breast cancers as well as uterine fibroids.

Fibroids are growths in the uterus that can cause pain, heavy bleeding, anemia, infertility and pregnancy problems.

Research shows that Black women are up to three times more likely than white women to develop fibroids.

“Several epidemiologic studies, including work conducted by my colleagues and myself, have raised concerns about associations between frequent use of chemical hair straighteners and increased risks of uterine fibroids, infertility and hormone-related cancers, including uterine, ovarian and breast cancers,” Lauren Wise, a professor at Boston University School of Public Health, told CNN in an email.

In a 2025 study, Wise found that recent use of temporary hair relaxers was more strongly linked to fibroid growth than permanent ones.